Lifecare AS (DE:LFC) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Lifecare ASA, a clinical-stage medical sensor company, reported steady progress towards automated production and continued development of its next-gen Continuous Glucose Monitor (CGM) in Q2 2024. The company, focusing on diabetes care, initiated in vivo longevity studies for their Sencell sensor and filed a patent for technology to detect a range of diseases. Additionally, Lifecare secured a strategic 80% stake in RemovAid, complementing its CGM sensor technology, and partnered with OneTwo Analytics to enhance glucose data analysis.
For further insights into DE:LFC stock, check out TipRanks’ Stock Analysis page.
